# KD Treatment for Super-refractory Status Epilepticus

> **NCT07496749** · NA · RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 84 (estimated)

## Conditions studied

- Super-refractory Status Epilepticus

## Interventions

- **OTHER:** the ketogenic diet
- **DRUG:** Standard Medical Therapy

## Key facts

- **NCT ID:** NCT07496749
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-20
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07496749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07496749, "KD Treatment for Super-refractory Status Epilepticus". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07496749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*